JP Patent

JP4648835B2 — ４−（３−クロロ−４−（シクロプロピルアミノカルボニル）アミノフェノキシ）−７−メトキシ−６−キノリンカルボキサミドの塩またはその溶媒和物の結晶およびそれらの製造方法

Assigned to Eisai R&D Management Co Ltd · Expires 2011-03-09 · 15y expired

What this patent protects

Patent listed against lazertinib-mesylate.

Drugs covered by this patent

Patent Metadata

Patent number
JP4648835B2
Jurisdiction
JP
Classification
—
Expires
2011-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Eisai R&D Management Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.